The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Disseminated Intravascular Coagulation Diagnosis Market Research Report 2024
Synopsis
Disseminated intravascular coagulation (DIC) is a rare but serious condition that causes abnormal blood clotting throughout the body's blood vessels. You may develop DIC if you have an infection or injury that affects the body's normal blood clotting process.DIC is an acquired clinic biological syndrome characterized by widespread coagulation activation, which results in fibrin deposition in the vasculature, organ dysfunction, clotting factor and platelet consumption, and life-threatening hemorrhage. Several underlying disorders can cause disseminated intravascular coagulation (sepsis, cancer, trauma, and pregnancy complicated with eclampsia or other calamities). The cornerstone therapeutic approaches are treating the underlying disease and eliminating the trigger mechanism. DIC-specific therapeutic strategies aim to reduce blood coagulation activation and bleeding risk. Few clinical trials use DIC as an entry criterion.
Global Disseminated Intravascular Coagulation Diagnosis market is projected to reach US$ 842.9 million in 2029, increasing from US$ 530 million in 2022, with the CAGR of 6.8% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Disseminated Intravascular Coagulation Diagnosis market research.
Disseminated Intravascular Coagulation (DIC) is a complex medical condition characterized by abnormal blood clotting and excessive bleeding. The diagnosis of DIC involves a combination of clinical assessment, laboratory tests, and the identification of underlying causes. Here are some key insights into the global DIC diagnosis market:
Market Outlook: The global DIC diagnosis market is driven by the increasing prevalence of conditions associated with DIC, such as sepsis and cancer. Additionally, advancements in laboratory diagnostics, growing adoption of POCT devices, and the need for timely diagnosis in critical care settings contribute to market growth. Key players in the global DIC diagnosis market include diagnostic companies, pharmaceutical companies, and medical device manufacturers.
Early and accurate diagnosis of DIC is crucial for timely intervention and management. Healthcare professionals must carefully evaluate clinical symptoms, perform appropriate laboratory tests, and identify the underlying causes to diagnose DIC effectively and develop appropriate treatment strategies.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Disseminated Intravascular Coagulation Diagnosis market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Abbott
AdvaCare Pharma
Axis-Shield Diagnostics
QuidelOrtho
CTK Biotech
AccuBioTech Co
Getein Biotech
PHC Holdings Corporation
Siemens Healthineers
Eurolyser Diagnostica GmbH
Segment by Type
Complete Blood Count with Blood Smear Exam
Partial Thromboplastin Time (PTT)
Prothrombin Time (PT)
Fibrinogen Blood Test
D-dimer Test
Others
Segment by Application
Hospital
Outpatient Center
Diagnostic and Research Laboratories
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Disseminated Intravascular Coagulation Diagnosis report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Disseminated intravascular coagulation (DIC) is a rare but serious condition that causes abnormal blood clotting throughout the body's blood vessels. You may develop DIC if you have an infection or injury that affects the body's normal blood clotting process.DIC is an acquired clinic biological syndrome characterized by widespread coagulation activation, which results in fibrin deposition in the vasculature, organ dysfunction, clotting factor and platelet consumption, and life-threatening hemorrhage. Several underlying disorders can cause disseminated intravascular coagulation (sepsis, cancer, trauma, and pregnancy complicated with eclampsia or other calamities). The cornerstone therapeutic approaches are treating the underlying disease and eliminating the trigger mechanism. DIC-specific therapeutic strategies aim to reduce blood coagulation activation and bleeding risk. Few clinical trials use DIC as an entry criterion.
Global Disseminated Intravascular Coagulation Diagnosis market is projected to reach US$ 842.9 million in 2029, increasing from US$ 530 million in 2022, with the CAGR of 6.8% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Disseminated Intravascular Coagulation Diagnosis market research.
Disseminated Intravascular Coagulation (DIC) is a complex medical condition characterized by abnormal blood clotting and excessive bleeding. The diagnosis of DIC involves a combination of clinical assessment, laboratory tests, and the identification of underlying causes. Here are some key insights into the global DIC diagnosis market:
Market Outlook: The global DIC diagnosis market is driven by the increasing prevalence of conditions associated with DIC, such as sepsis and cancer. Additionally, advancements in laboratory diagnostics, growing adoption of POCT devices, and the need for timely diagnosis in critical care settings contribute to market growth. Key players in the global DIC diagnosis market include diagnostic companies, pharmaceutical companies, and medical device manufacturers.
Early and accurate diagnosis of DIC is crucial for timely intervention and management. Healthcare professionals must carefully evaluate clinical symptoms, perform appropriate laboratory tests, and identify the underlying causes to diagnose DIC effectively and develop appropriate treatment strategies.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Disseminated Intravascular Coagulation Diagnosis market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Abbott
AdvaCare Pharma
Axis-Shield Diagnostics
QuidelOrtho
CTK Biotech
AccuBioTech Co
Getein Biotech
PHC Holdings Corporation
Siemens Healthineers
Eurolyser Diagnostica GmbH
Segment by Type
Complete Blood Count with Blood Smear Exam
Partial Thromboplastin Time (PTT)
Prothrombin Time (PT)
Fibrinogen Blood Test
D-dimer Test
Others
Segment by Application
Hospital
Outpatient Center
Diagnostic and Research Laboratories
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Disseminated Intravascular Coagulation Diagnosis report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Disseminated Intravascular Coagulation Diagnosis Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Complete Blood Count with Blood Smear Exam
1.2.3 Partial Thromboplastin Time (PTT)
1.2.4 Prothrombin Time (PT)
1.2.5 Fibrinogen Blood Test
1.2.6 D-dimer Test
1.2.7 Others
1.3 Market by Application
1.3.1 Global Disseminated Intravascular Coagulation Diagnosis Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Outpatient Center
1.3.4 Diagnostic and Research Laboratories
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Disseminated Intravascular Coagulation Diagnosis Market Perspective (2018-2029)
2.2 Disseminated Intravascular Coagulation Diagnosis Growth Trends by Region
2.2.1 Global Disseminated Intravascular Coagulation Diagnosis Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Disseminated Intravascular Coagulation Diagnosis Historic Market Size by Region (2018-2023)
2.2.3 Disseminated Intravascular Coagulation Diagnosis Forecasted Market Size by Region (2024-2029)
2.3 Disseminated Intravascular Coagulation Diagnosis Market Dynamics
2.3.1 Disseminated Intravascular Coagulation Diagnosis Industry Trends
2.3.2 Disseminated Intravascular Coagulation Diagnosis Market Drivers
2.3.3 Disseminated Intravascular Coagulation Diagnosis Market Challenges
2.3.4 Disseminated Intravascular Coagulation Diagnosis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Disseminated Intravascular Coagulation Diagnosis Players by Revenue
3.1.1 Global Top Disseminated Intravascular Coagulation Diagnosis Players by Revenue (2018-2023)
3.1.2 Global Disseminated Intravascular Coagulation Diagnosis Revenue Market Share by Players (2018-2023)
3.2 Global Disseminated Intravascular Coagulation Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Disseminated Intravascular Coagulation Diagnosis Revenue
3.4 Global Disseminated Intravascular Coagulation Diagnosis Market Concentration Ratio
3.4.1 Global Disseminated Intravascular Coagulation Diagnosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Disseminated Intravascular Coagulation Diagnosis Revenue in 2022
3.5 Disseminated Intravascular Coagulation Diagnosis Key Players Head office and Area Served
3.6 Key Players Disseminated Intravascular Coagulation Diagnosis Product Solution and Service
3.7 Date of Enter into Disseminated Intravascular Coagulation Diagnosis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Disseminated Intravascular Coagulation Diagnosis Breakdown Data by Type
4.1 Global Disseminated Intravascular Coagulation Diagnosis Historic Market Size by Type (2018-2023)
4.2 Global Disseminated Intravascular Coagulation Diagnosis Forecasted Market Size by Type (2024-2029)
5 Disseminated Intravascular Coagulation Diagnosis Breakdown Data by Application
5.1 Global Disseminated Intravascular Coagulation Diagnosis Historic Market Size by Application (2018-2023)
5.2 Global Disseminated Intravascular Coagulation Diagnosis Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Disseminated Intravascular Coagulation Diagnosis Market Size (2018-2029)
6.2 North America Disseminated Intravascular Coagulation Diagnosis Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Disseminated Intravascular Coagulation Diagnosis Market Size by Country (2018-2023)
6.4 North America Disseminated Intravascular Coagulation Diagnosis Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Disseminated Intravascular Coagulation Diagnosis Market Size (2018-2029)
7.2 Europe Disseminated Intravascular Coagulation Diagnosis Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Disseminated Intravascular Coagulation Diagnosis Market Size by Country (2018-2023)
7.4 Europe Disseminated Intravascular Coagulation Diagnosis Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Disseminated Intravascular Coagulation Diagnosis Market Size (2018-2029)
8.2 Asia-Pacific Disseminated Intravascular Coagulation Diagnosis Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Disseminated Intravascular Coagulation Diagnosis Market Size by Region (2018-2023)
8.4 Asia-Pacific Disseminated Intravascular Coagulation Diagnosis Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Disseminated Intravascular Coagulation Diagnosis Market Size (2018-2029)
9.2 Latin America Disseminated Intravascular Coagulation Diagnosis Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Disseminated Intravascular Coagulation Diagnosis Market Size by Country (2018-2023)
9.4 Latin America Disseminated Intravascular Coagulation Diagnosis Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Disseminated Intravascular Coagulation Diagnosis Market Size (2018-2029)
10.2 Middle East & Africa Disseminated Intravascular Coagulation Diagnosis Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Disseminated Intravascular Coagulation Diagnosis Market Size by Country (2018-2023)
10.4 Middle East & Africa Disseminated Intravascular Coagulation Diagnosis Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Disseminated Intravascular Coagulation Diagnosis Introduction
11.1.4 Abbott Revenue in Disseminated Intravascular Coagulation Diagnosis Business (2018-2023)
11.1.5 Abbott Recent Development
11.2 AdvaCare Pharma
11.2.1 AdvaCare Pharma Company Detail
11.2.2 AdvaCare Pharma Business Overview
11.2.3 AdvaCare Pharma Disseminated Intravascular Coagulation Diagnosis Introduction
11.2.4 AdvaCare Pharma Revenue in Disseminated Intravascular Coagulation Diagnosis Business (2018-2023)
11.2.5 AdvaCare Pharma Recent Development
11.3 Axis-Shield Diagnostics
11.3.1 Axis-Shield Diagnostics Company Detail
11.3.2 Axis-Shield Diagnostics Business Overview
11.3.3 Axis-Shield Diagnostics Disseminated Intravascular Coagulation Diagnosis Introduction
11.3.4 Axis-Shield Diagnostics Revenue in Disseminated Intravascular Coagulation Diagnosis Business (2018-2023)
11.3.5 Axis-Shield Diagnostics Recent Development
11.4 QuidelOrtho
11.4.1 QuidelOrtho Company Detail
11.4.2 QuidelOrtho Business Overview
11.4.3 QuidelOrtho Disseminated Intravascular Coagulation Diagnosis Introduction
11.4.4 QuidelOrtho Revenue in Disseminated Intravascular Coagulation Diagnosis Business (2018-2023)
11.4.5 QuidelOrtho Recent Development
11.5 CTK Biotech
11.5.1 CTK Biotech Company Detail
11.5.2 CTK Biotech Business Overview
11.5.3 CTK Biotech Disseminated Intravascular Coagulation Diagnosis Introduction
11.5.4 CTK Biotech Revenue in Disseminated Intravascular Coagulation Diagnosis Business (2018-2023)
11.5.5 CTK Biotech Recent Development
11.6 AccuBioTech Co
11.6.1 AccuBioTech Co Company Detail
11.6.2 AccuBioTech Co Business Overview
11.6.3 AccuBioTech Co Disseminated Intravascular Coagulation Diagnosis Introduction
11.6.4 AccuBioTech Co Revenue in Disseminated Intravascular Coagulation Diagnosis Business (2018-2023)
11.6.5 AccuBioTech Co Recent Development
11.7 Getein Biotech
11.7.1 Getein Biotech Company Detail
11.7.2 Getein Biotech Business Overview
11.7.3 Getein Biotech Disseminated Intravascular Coagulation Diagnosis Introduction
11.7.4 Getein Biotech Revenue in Disseminated Intravascular Coagulation Diagnosis Business (2018-2023)
11.7.5 Getein Biotech Recent Development
11.8 PHC Holdings Corporation
11.8.1 PHC Holdings Corporation Company Detail
11.8.2 PHC Holdings Corporation Business Overview
11.8.3 PHC Holdings Corporation Disseminated Intravascular Coagulation Diagnosis Introduction
11.8.4 PHC Holdings Corporation Revenue in Disseminated Intravascular Coagulation Diagnosis Business (2018-2023)
11.8.5 PHC Holdings Corporation Recent Development
11.9 Siemens Healthineers
11.9.1 Siemens Healthineers Company Detail
11.9.2 Siemens Healthineers Business Overview
11.9.3 Siemens Healthineers Disseminated Intravascular Coagulation Diagnosis Introduction
11.9.4 Siemens Healthineers Revenue in Disseminated Intravascular Coagulation Diagnosis Business (2018-2023)
11.9.5 Siemens Healthineers Recent Development
11.10 Eurolyser Diagnostica GmbH
11.10.1 Eurolyser Diagnostica GmbH Company Detail
11.10.2 Eurolyser Diagnostica GmbH Business Overview
11.10.3 Eurolyser Diagnostica GmbH Disseminated Intravascular Coagulation Diagnosis Introduction
11.10.4 Eurolyser Diagnostica GmbH Revenue in Disseminated Intravascular Coagulation Diagnosis Business (2018-2023)
11.10.5 Eurolyser Diagnostica GmbH Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
